Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region

NCT03349164 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-11-21

No results posted yet for this study

Summary

There will be assessment of patients after acute pulmonary embolism for the development of CTEPH

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension

Interventions

DIAGNOSTIC_TEST

acute PE survivors

Patients from this group will be assessed by cardiologist, echocardiography and VQ scanning

Sponsors & Collaborators

  • Novosibirsk Scientific Research Institute for Circulatory Pathology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-11-10
Completion
2018-03-10

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349164 on ClinicalTrials.gov